Seeking Alpha

Jason Napodano, CFA  

View Jason Napodano, CFA's StockTalks BY TICKER:

  • Jason Napodano, CFA
    Auspex Hits Home Run With Phase 3 Data In Huntington's Chorea $ASPX http://seekingalpha.com/a/1n8sz
    12/17/14
    Reply
      • Jason Napodano, CFA
        Auspex Hits Homerun With Phase 3 Data In Huntington's Chorea $ASPX http://seekingalpha.com/p/24e1t
        12/17/14
        Reply (1)
        • jacobite47: Thank you Jason.
          12/17/14
          • Jason Napodano, CFA
            Cynapsus Shares Set For Major Move Higher On Backs Of Positive Phase 2 Data $CYNAF http://seekingalpha.com/p/22lpf
            11/19/14
            Reply (3)
          • View all 3 replies
            • TimeOnTarget: I'll go better than brichnyc: Great Job. You were on Cynapsus before anyone else I saw, you were on it hard, and you have just nailed it.
              11/19/14
            • freedom_has_few_friends: Yes, thank you Jason for pointing me to this investment. Looking more and more like they have a promising treatment here.
              11/19/14
              • Jason Napodano, CFA
                Buy Auspex Ahead Of Pivotal Phase 3 Data In December 2014 $ASPX http://seekingalpha.com/a/1lb4n
                11/13/14
                Reply
                  • Jason Napodano, CFA
                    Article (and report link inside) on a new player in the Fish Oil / Omega-3 market >> http://bit.ly/1p6lU4B $MTNB $AMRN $GSK $AZN
                    10/30/14
                    Reply
                      • Jason Napodano, CFA
                        Neurotrope Tackles Alzheimer's Disease With Novel Mechanism $NTRP http://seekingalpha.com/a/1j7g7
                        10/21/14
                        Reply
                          • Jason Napodano, CFA
                            InVivo, Neuralstem Treat Spinal Cord Injury Patients $CUR http://seekingalpha.com/a/1iyk7
                            10/16/14
                            Reply (1)
                            • matratra: CUR- In vitro would be welcome.
                              10/16/14